A common human TLR1 polymorphism regulates the innate immune response to lipopeptides

Toll‐like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses t...

Full description

Saved in:

Bibliographic Details
Published in	European Journal of Immunology Vol. 37; no. 8; pp. 2280 - 2289
Main Authors	Hawn, Thomas R., Misch, E. Ann, Dunstan, Sarah J., Thwaites, Guy E., Lan, Nguyen T. N., Quy, Hoang T., Chau, Tran T. H., Rodrigues, Stephanie, Nachman, Alex, Janer, Marta, Hien, Tran T., Farrar, Jeremy J., Aderem, Alan
Format	Journal Article
Language	English
Published	Weinheim WILEY‐VCH Verlag 01.08.2007
Subjects	Bacterial Proteins - immunology Base Sequence Fluorescent Antibody Technique Genetics Humans Immunity, Innate Immunoblotting Infectious diseases Inflammation Innate immunity Lipoproteins - immunology Mycobacterium tuberculosis Mycobacterium tuberculosis - immunology NF-kappa B Polymerase Chain Reaction Polymorphism, Single Nucleotide Toll-Like Receptor 1 - genetics Transfection
Online Access	Get full text

Cover

Loading…

Abstract	Toll‐like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter‐individual variation in the immune response. We sequenced the coding region of TLR1 and found a non‐synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide‐induced NF‐κB signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis. Furthermore, individuals with the 602II genotype produced substantially more IL‐6 than those with the 602SS variant in a lipopeptide‐stimulated whole‐blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens. See accompanying article: http://dx.doi.org/10.1002/eji.200737604
AbstractList	Toll‐like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter‐individual variation in the immune response. We sequenced the coding region of TLR1 and found a non‐synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide‐induced NF‐κB signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis. Furthermore, individuals with the 602II genotype produced substantially more IL‐6 than those with the 602SS variant in a lipopeptide‐stimulated whole‐blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens. See accompanying article: http://dx.doi.org/10.1002/eji.200737604 Toll-like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter-individual variation in the immune response. We sequenced the coding region of TLR1 and found a non-synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide-induced NF-kappaB signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis. Furthermore, individuals with the 602II genotype produced substantially more IL-6 than those with the 602SS variant in a lipopeptide-stimulated whole-blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens. Toll-like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter-individual variation in the immune response. We sequenced the coding region of TLR1 and found a non-synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide-induced NF-B signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis. Furthermore, individuals with the 602II genotype produced substantially more IL-6 than those with the 602SS variant in a lipopeptide-stimulated whole-blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens. See accompanying article: http://dx.doi.org/10.1002/eji.200737604 . Toll‐like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways and are associated with susceptibility to infection. Lipopeptides are present in a wide variety of microbes and stimulate immune responses through TLR1/2 or TLR2/6 heterodimers. It is not currently known whether polymorphisms in TLR1 regulate the innate immune response. We stimulated human whole blood with triacylated lipopeptide, a ligand for TLR1/2 heterodimers, and found substantial inter‐individual variation in the immune response. We sequenced the coding region of TLR1 and found a non‐synonymous polymorphism, I602S (base pair T1805G), that regulated signalling. In comparison to TLR1_602S, the 602I variant mediated substantially greater basal and lipopeptide‐induced NF‐κB signalling in transfected HEK293 cells. These signalling differences among TLR1 variants were also found with stimulation by extracts of Mycobacterium tuberculosis . Furthermore, individuals with the 602II genotype produced substantially more IL‐6 than those with the 602SS variant in a lipopeptide‐stimulated whole‐blood cytokine assay. Together, these observations demonstrate that variation in the inflammatory response to bacterial lipopeptides is regulated by a common TLR1 transmembrane domain polymorphism that could potentially impact the innate immune response and clinical susceptibility to a wide spectrum of pathogens. See accompanying article: http://dx.doi.org/10.1002/eji.200737604
Author	Dunstan, Sarah J. Chau, Tran T. H. Lan, Nguyen T. N. Hawn, Thomas R. Nachman, Alex Hien, Tran T. Misch, E. Ann Farrar, Jeremy J. Rodrigues, Stephanie Quy, Hoang T. Thwaites, Guy E. Janer, Marta Aderem, Alan
Author_xml	– sequence: 1 givenname: Thomas R. surname: Hawn fullname: Hawn, Thomas R. email: thawn@u.washington.edu – sequence: 2 givenname: E. Ann surname: Misch fullname: Misch, E. Ann – sequence: 3 givenname: Sarah J. surname: Dunstan fullname: Dunstan, Sarah J. – sequence: 4 givenname: Guy E. surname: Thwaites fullname: Thwaites, Guy E. – sequence: 5 givenname: Nguyen T. N. surname: Lan fullname: Lan, Nguyen T. N. – sequence: 6 givenname: Hoang T. surname: Quy fullname: Quy, Hoang T. – sequence: 7 givenname: Tran T. H. surname: Chau fullname: Chau, Tran T. H. – sequence: 8 givenname: Stephanie surname: Rodrigues fullname: Rodrigues, Stephanie – sequence: 9 givenname: Alex surname: Nachman fullname: Nachman, Alex – sequence: 10 givenname: Marta surname: Janer fullname: Janer, Marta – sequence: 11 givenname: Tran T. surname: Hien fullname: Hien, Tran T. – sequence: 12 givenname: Jeremy J. surname: Farrar fullname: Farrar, Jeremy J. – sequence: 13 givenname: Alan surname: Aderem fullname: Aderem, Alan
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/17595679$$D View this record in MEDLINE/PubMed
BookMark	eNqFkEtLw0AURgdRbKsu3cqs3EXvJPPoLEupLwqC1HVIJjd2JDMTMwnSf2-kRXe6uh_cw1mcGTn2wSMhlwxuGEB6i-_2JgVQmYKMH5EpEylLOOPsmEwBGE9SPYcJmcX4DgBaCn1KJkwJLaTSU_K6oCY4FzzdDq7wdLN-YbQNzc6Frt3a6GiHb0NT9Bhpv0VqvR83tc4NHsdfbIOPSPtAG9uGFtveVhjPyUldNBEvDveMbO5Wm-VDsn6-f1wu1onhSvAEywzngmujVFGXpmBVanjJhYZ5jUYoLjIBRtaQVbVUBehaClmZuoLSKMDsjFzvtW0XPgaMfe5sNNg0hccwxFzOGUip4V-QacWYhGwEkz1ouhBjh3XedtYV3S5nkH_3zsfe-U_vkb86iIfSYfVLHwKPgNoDn7bB3d-2fPX0-Kv-AllejlY
CitedBy_id	crossref_primary_10_1016_j_intimp_2013_03_017 crossref_primary_10_1371_journal_pone_0007803 crossref_primary_10_1042_CS20070214 crossref_primary_10_1002_evl3_140 crossref_primary_10_1128_MMBR_00025_10 crossref_primary_10_1186_1755_1536_3_23 crossref_primary_10_1016_j_actatropica_2015_03_007 crossref_primary_10_1111_iji_12118 crossref_primary_10_1155_2011_814943 crossref_primary_10_4049_jimmunol_1201545 crossref_primary_10_5812_jjm_58351 crossref_primary_10_1016_j_humimm_2014_06_014 crossref_primary_10_1146_annurev_immunol_030409_101335 crossref_primary_10_1186_1471_2148_12_122 crossref_primary_10_3389_fgene_2022_952219 crossref_primary_10_1016_j_bbamem_2014_01_020 crossref_primary_10_1074_jbc_M112_342717 crossref_primary_10_1016_j_mehy_2009_05_014 crossref_primary_10_2165_11311110_000000000_00000 crossref_primary_10_1155_2012_415057 crossref_primary_10_1016_j_healun_2009_05_026 crossref_primary_10_1002_art_34383 crossref_primary_10_1080_23808993_2020_1816136 crossref_primary_10_1016_j_gene_2011_12_008 crossref_primary_10_1371_journal_pone_0013759 crossref_primary_10_1038_gene_2014_10 crossref_primary_10_1093_infdis_jir882 crossref_primary_10_1038_s41598_017_07250_4 crossref_primary_10_1590_S0074_02762012000900020 crossref_primary_10_1128_IAI_00816_09 crossref_primary_10_1371_journal_ppat_1001189 crossref_primary_10_3389_fimmu_2018_01455 crossref_primary_10_1016_j_intimp_2018_03_002 crossref_primary_10_3390_pathogens10020120 crossref_primary_10_1038_gene_2011_49 crossref_primary_10_1186_s13104_015_1740_5 crossref_primary_10_2217_fmb_11_39 crossref_primary_10_4049_jimmunol_1500856 crossref_primary_10_3851_IMP1820 crossref_primary_10_1007_s40121_016_0138_6 crossref_primary_10_1007_s11908_018_0611_3 crossref_primary_10_1155_2010_814086 crossref_primary_10_1038_s41584_021_00648_5 crossref_primary_10_1016_j_anndiagpath_2022_152080 crossref_primary_10_1186_s12936_015_1071_y crossref_primary_10_1016_j_dci_2010_09_008 crossref_primary_10_1128_IAI_00618_09 crossref_primary_10_1002_ijc_23826 crossref_primary_10_3201_eid2804_211831 crossref_primary_10_1111_bjh_15998 crossref_primary_10_1111_j_1365_3083_2012_02696_x crossref_primary_10_1165_rcmb_2014_0114OC crossref_primary_10_1016_j_dci_2008_06_001 crossref_primary_10_1016_j_tube_2015_02_045 crossref_primary_10_1007_s12026_015_8749_7 crossref_primary_10_1093_molbev_msq104 crossref_primary_10_1186_s12879_015_0833_z crossref_primary_10_1111_j_1744_313X_2011_01077_x crossref_primary_10_1038_s41577_018_0025_3 crossref_primary_10_1200_JCO_2007_14_6423 crossref_primary_10_1016_j_humimm_2017_11_007 crossref_primary_10_1017_erm_2013_10 crossref_primary_10_1007_s10067_023_06702_9 crossref_primary_10_56407_2313_092X_2022_26_2__4 crossref_primary_10_1016_j_tube_2014_12_001 crossref_primary_10_1111_cmi_12795 crossref_primary_10_1371_journal_pone_0063357 crossref_primary_10_1053_j_gastro_2022_01_011 crossref_primary_10_1128_AAC_00878_16 crossref_primary_10_3748_wjg_v20_i32_11116 crossref_primary_10_1097_OLQ_0000000000000149 crossref_primary_10_1111_j_1600_065X_2010_00996_x crossref_primary_10_1038_gene_2016_51 crossref_primary_10_1038_sj_onc_1210912 crossref_primary_10_1093_infdis_jir822 crossref_primary_10_1371_journal_pntd_0000231 crossref_primary_10_1038_ejhg_2013_194 crossref_primary_10_1042_BST0351445 crossref_primary_10_1186_1742_4933_10_4 crossref_primary_10_1111_hel_12001 crossref_primary_10_1038_s41467_023_37042_6 crossref_primary_10_1007_s00335_010_9301_7 crossref_primary_10_1016_j_vetimm_2010_06_015 crossref_primary_10_1111_iji_12676 crossref_primary_10_3389_fimmu_2021_714808 crossref_primary_10_1016_j_molimm_2009_03_024 crossref_primary_10_1371_journal_ppat_1000979 crossref_primary_10_1371_journal_pgen_1000562 crossref_primary_10_1371_journal_pone_0195392 crossref_primary_10_17816_MAJ90324 crossref_primary_10_1186_1297_9716_43_17 crossref_primary_10_1016_j_xhgg_2021_100071 crossref_primary_10_18632_oncotarget_23067 crossref_primary_10_1038_nri3421 crossref_primary_10_1016_j_humimm_2010_07_009 crossref_primary_10_1158_1535_7163_MCT_15_0931 crossref_primary_10_1371_journal_pone_0083285 crossref_primary_10_4049_jimmunol_1202033 crossref_primary_10_1016_j_micinf_2008_07_039 crossref_primary_10_1146_annurev_genet_080320_010449 crossref_primary_10_1093_infdis_jis922 crossref_primary_10_31393_reports_vnmedical_2023_27_2__28 crossref_primary_10_1093_carcin_bgn262 crossref_primary_10_1111_imr_12381 crossref_primary_10_1016_j_jim_2015_12_001 crossref_primary_10_1111_cei_12578 crossref_primary_10_1111_sji_12771 crossref_primary_10_1371_journal_pone_0139711 crossref_primary_10_1016_j_ijantimicag_2008_08_002 crossref_primary_10_1038_gene_2014_54 crossref_primary_10_1016_j_vetimm_2008_12_007 crossref_primary_10_1016_j_fsi_2023_109021 crossref_primary_10_4155_tde_12_52 crossref_primary_10_1002_humu_21486 crossref_primary_10_1038_gene_2010_14 crossref_primary_10_1111_j_1399_0039_2011_01808_x crossref_primary_10_1111_apa_13984 crossref_primary_10_1016_j_jcf_2013_01_001 crossref_primary_10_1038_mi_2011_14 crossref_primary_10_4049_jimmunol_1401185 crossref_primary_10_1111_sji_12066 crossref_primary_10_3382_ps_2011_01489 crossref_primary_10_1186_1471_2156_10_21 crossref_primary_10_1016_j_bmc_2018_07_013 crossref_primary_10_1189_jlb_0409233 crossref_primary_10_3390_tropicalmed8100473 crossref_primary_10_1016_j_chom_2015_12_006 crossref_primary_10_1038_gene_2015_50 crossref_primary_10_1242_dmm_010215 crossref_primary_10_1590_S0100_879X2009000400002 crossref_primary_10_1111_j_1398_9995_2009_02066_x crossref_primary_10_1007_s10096_009_0746_0 crossref_primary_10_1371_journal_ppat_1003397 crossref_primary_10_3389_fimmu_2023_1163781 crossref_primary_10_1038_gene_2013_34 crossref_primary_10_1016_j_bbamem_2017_07_010 crossref_primary_10_1371_journal_pone_0001318 crossref_primary_10_1097_QCO_0b013e3282f88b5d crossref_primary_10_15832_ankutbd_349728 crossref_primary_10_1016_j_cyto_2019_154897 crossref_primary_10_1586_14787210_6_4_479 crossref_primary_10_1164_rccm_200803_462OC crossref_primary_10_1007_s12026_015_8640_6 crossref_primary_10_1093_infdis_jit133 crossref_primary_10_1016_j_ijmm_2016_05_012 crossref_primary_10_1007_s10528_012_9513_5 crossref_primary_10_1086_590440 crossref_primary_10_1097_QCO_0b013e3282f88ba3 crossref_primary_10_1016_j_meegid_2015_07_004 crossref_primary_10_1371_journal_ppat_1002174
Cites_doi	10.1073/pnas.0506803102 10.1038/35021228 10.1038/nri1391 10.1073/pnas.0501165102 10.1126/science.1081902 10.1073/pnas.96.25.14459 10.1016/j.clim.2006.02.003 10.1126/science.285.5428.732 10.4049/jimmunol.167.2.987 10.1128/IAI.72.3.1657-1665.2004 10.1146/annurev.immunol.20.083001.084359 10.1086/378095 10.1038/76048 10.1073/pnas.0409831102 10.1016/j.clim.2006.01.005 10.1086/507907 10.1074/jbc.M610340200 10.1016/S1473-3099(05)01308-3 10.1038/35103577 10.1146/annurev.genom.2.1.373 10.1111/j.1365-3083.1988.tb02404.x 10.1038/nature04946 10.1084/jem.20022078 10.1084/jem.20031220 10.1038/ng1976 10.1056/NEJM198803243181202 10.1006/cyto.1998.0471 10.1038/ni1116 10.1101/gr.8.3.195 10.1016/j.humimm.2005.04.009 10.4049/jimmunol.169.1.10 10.1016/j.cell.2006.02.015 10.1016/S1286-4579(02)01611-8 10.1177/1536867X0100100104 10.1097/01.MIB.0000195389.11645.ab 10.4049/jimmunol.163.7.3920 10.1038/nm864 10.1128/IAI.68.11.6398-6401.2000 10.1016/S0140-6736(96)06413-6 10.1074/jbc.M504320200 10.4049/jimmunol.170.7.3451 10.1002/eji.200424955 10.4049/jimmunol.175.4.2570 10.1002/1521-4141(200212)32:12<3337::AID-IMMU3337>3.0.CO;2-# 10.1084/jem.20051782 10.1146/annurev.immunol.20.081501.125851 10.1074/jbc.M512525200 10.4049/jimmunol.175.4.2534 10.1093/intimm/13.7.933
ContentType	Journal Article
Copyright	Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml	– notice: Copyright © 2007 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
DBID	CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7X8
DOI	10.1002/eji.200737034
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1521-4141 1365-2567
EndPage	2289
ExternalDocumentID	10_1002_eji_200737034 17595679 EJI200737034
Genre	article Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: Wellcome Trust of Great Britain – fundername: National Institute of Health – fundername: Dana Foundation – fundername: PHS HHS grantid: HHSN266200400091C – fundername: Wellcome Trust
GroupedDBID	--- .3N .55 .GA .GJ .HR .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHMBA AI. AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M J5H JPC KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OHT OIG OK1 OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 UPT V2E VH1 W8V W99 WBKPD WHWMO WIB WIH WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXSBR X7M XG1 XPP XV2 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL CITATION -~X 29I 2WC 36B 52R 52V 5HH 5LA 7QL 7T5 A01 A8Z ABDBF ABXGK ACGFO ACGOF ACIWK ACMXC ACNCT ADBTR AEGXH AFEBI AIACR AIAGR AOIJS BAWUL C1K C45 CAG COF D-6 D-7 DIK DRMAN E3Z EAD EAP EAS EBB EBC EBX EMB EMK EPT ESTFP ESX EX3 FD6 FIJ FUBAC GX1 H94 HZI IH2 IHE IPNFZ K48 KBYEO MRMAN MSMAN MXMAN OBC OBS P2Z P4B Q~Q RPM TR2 TUS V8K WH7 WIJ WOW WXI YF5 YFH YOC YUY 7X8
ID	FETCH-LOGICAL-c4754-eb3e8549c77afbca1d2c4b45908fec5745350c6f03df67a09f656dcfd0bc70e3
IEDL.DBID	DR2
ISSN	0014-2980
IngestDate	Wed Dec 04 14:57:47 EST 2024 Wed Dec 04 00:36:35 EST 2024 Fri Dec 06 00:48:50 EST 2024 Sat Sep 28 07:42:34 EDT 2024 Sat Aug 24 00:41:40 EDT 2024
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	8
Language	English
License	http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4754-eb3e8549c77afbca1d2c4b45908fec5745350c6f03df67a09f656dcfd0bc70e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/eji.200737034
PMID	17595679
PQID	19711603
PQPubID	23462
PageCount	10
ParticipantIDs	proquest_miscellaneous_68106690 proquest_miscellaneous_19711603 crossref_primary_10_1002_eji_200737034 pubmed_primary_17595679 wiley_primary_10_1002_eji_200737034_EJI200737034
PublicationCentury	2000
PublicationDate	August 2007
PublicationDateYYYYMMDD	2007-08-01
PublicationDate_xml	– month: 08 year: 2007 text: August 2007
PublicationDecade	2000
PublicationPlace	Weinheim
PublicationPlace_xml	– name: Weinheim – name: Germany
PublicationTitle	European Journal of Immunology
PublicationTitleAlternate	Eur J Immunol
PublicationYear	2007
Publisher	WILEY‐VCH Verlag
Publisher_xml	– name: WILEY‐VCH Verlag
References	2007; 39 2001; 167 2006; 119 2005; 175 2000; 25 2006; 12 2007; 282 2000; 68 2002; 32 2004; 4 1999; 285 2004; 5 1999; 163 2003; 170 2002; 4 2006; 194 2003; 212 2003; 299 2005; 66 2003; 198 2003; 197 2005; 280 2004; 72 1997; 349 2002; 20 2005; 102 2005; 202 2002; 169 1988; 27 2000; 406 2003; 9 2005; 5 1999; 11 2006; 120 2001; 2 1999; 96 2001; 1 2006; 281 1988; 318 2001; 13 2006; 442 2003; 188 2005; 35 2006; 103 2006; 124 1998; 8 17654751 - Eur J Immunol. 2007 Aug;37(8):2059-62 e_1_2_7_5_2 e_1_2_7_3_2 Schroder N. W. (e_1_2_7_21_2) 2005; 5 e_1_2_7_9_2 e_1_2_7_7_2 e_1_2_7_19_2 e_1_2_7_17_2 e_1_2_7_15_2 e_1_2_7_1_2 e_1_2_7_13_2 e_1_2_7_41_2 e_1_2_7_11_2 e_1_2_7_43_2 e_1_2_7_45_2 Mander A. P. (e_1_2_7_50_2) 2001; 1 e_1_2_7_47_2 e_1_2_7_26_2 e_1_2_7_49_2 e_1_2_7_28_2 e_1_2_7_25_2 e_1_2_7_23_2 e_1_2_7_31_2 e_1_2_7_33_2 e_1_2_7_35_2 e_1_2_7_37_2 e_1_2_7_39_2 e_1_2_7_4_2 e_1_2_7_2_2 e_1_2_7_8_2 e_1_2_7_6_2 e_1_2_7_18_2 e_1_2_7_16_2 e_1_2_7_14_2 e_1_2_7_40_2 e_1_2_7_12_2 e_1_2_7_42_2 e_1_2_7_10_2 e_1_2_7_44_2 e_1_2_7_46_2 e_1_2_7_27_2 e_1_2_7_29_2 Means T. K. (e_1_2_7_30_2) 1999; 163 e_1_2_7_24_2 Storm N. (e_1_2_7_48_2) 2003; 212 e_1_2_7_22_2 e_1_2_7_32_2 e_1_2_7_20_2 e_1_2_7_34_2 e_1_2_7_36_2 e_1_2_7_38_2
References_xml	– volume: 96 start-page: 14459 year: 1999 end-page: 14463 article-title: Toll‐like receptor‐2 mediates mycobacteria‐induced pro‐inflammatory signaling in macrophages. publication-title: Proc. Natl. Acad. Sci. USA – volume: 8 start-page: 195 year: 1998 end-page: 202 article-title: Consed: A graphical tool for sequence finishing. publication-title: Genome Res. – volume: 442 start-page: 39 year: 2006 end-page: 44 article-title: Intracellular pattern recognition receptors in the host response. publication-title: Nature – volume: 198 start-page: 1563 year: 2003 end-page: 1572 article-title: A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires’ disease. publication-title: J. Exp. Med. – volume: 169 start-page: 10 year: 2002 end-page: 14 article-title: Cutting edge: Role of Toll‐like receptor 1 in mediating immune response to microbial lipoproteins. publication-title: J. Immunol. – volume: 119 start-page: 188 year: 2006 end-page: 194 article-title: A missense mutation of the Toll‐like receptor 3 gene in a patient with influenza‐associated encephalopathy. publication-title: Clin. Immunol. – volume: 68 start-page: 6398 year: 2000 end-page: 6401 article-title: A novel polymorphism in the Toll‐like receptor 2 gene and its potential association with staphylococcal infection. publication-title: Infect. Immun. – volume: 5 start-page: 975 year: 2004 end-page: 979 article-title: Toll‐like receptors in the pathogenesis of human disease. publication-title: Nat. Immunol. – volume: 318 start-page: 727 year: 1988 end-page: 732 article-title: Genetic and environmental influences on premature death in adult adoptees. publication-title: N. Engl. J. Med. – volume: 66 start-page: 842 year: 2005 end-page: 847 article-title: Hyper‐IgE syndrome is not associated with defects in several candidate Toll‐like receptor pathway genes. publication-title: Hum. Immunol. – volume: 9 start-page: 525 year: 2003 end-page: 532 article-title: Activation and regulation of Toll‐like receptors 2 and 1 in human leprosy. publication-title: Nat. Med. – volume: 102 start-page: 10593 year: 2005 end-page: 10597 article-title: A stop codon polymorphism of Toll‐like receptor 5 is associated with resistance to systemic lupus erythematosus. publication-title: Proc. Natl. Acad. Sci. USA – volume: 2 start-page: 373 year: 2001 end-page: 400 article-title: The genomics and genetics of human infectious disease susceptibility. publication-title: Annu. Rev. Genomics Hum. Genet. – volume: 406 start-page: 782 year: 2000 end-page: 787 article-title: Toll‐like receptors in the induction of the innate immune response. publication-title: Nature – volume: 282 start-page: 13190 year: 2007 end-page: 13198 article-title: Cellular recognition of Tri‐myristoylated peptide or enterobacterial LPS both TLR2 and TLR4. publication-title: J. Biol. Chem. – volume: 32 start-page: 3337 year: 2002 end-page: 3347 article-title: Differential recognition of structural details of bacterial lipopeptides by Toll‐like receptors. publication-title: Eur. J. Immunol. – volume: 197 start-page: 1787 year: 2003 end-page: 1791 article-title: Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll‐like receptor 4 gene show no deficit in lipopolysaccharide signalling. publication-title: J. Exp. Med. – volume: 212 start-page: 241 year: 2003 end-page: 262 article-title: MALDI‐TOF mass spectrometry‐based SNP genotyping. publication-title: Methods Mol. Biol. – volume: 13 start-page: 933 year: 2001 end-page: 940 article-title: Discrimination of bacterial lipoproteins by Toll‐like receptor 6. publication-title: Int. Immunol. – volume: 35 start-page: 282 year: 2005 end-page: 289 article-title: Toll‐like receptor 6‐independent signaling by diacylated lipopeptides. publication-title: Eur. J. Immunol. – volume: 20 start-page: 581 year: 2002 end-page: 620 article-title: Genetic dissection of immunity to mycobacteria: The human model. publication-title: Annu. Rev. Immunol. – volume: 12 start-page: 1 year: 2006 end-page: 8 article-title: Toll‐like receptor‐1, ‐2, and ‐6 polymorphisms influence disease extension in inflammatory bowel diseases. publication-title: Inflamm. Bowel Dis. – volume: 280 start-page: 36616 year: 2005 end-page: 36625 article-title: Domain exchange between human Toll‐like receptors 1 and 6 reveals a region required for lipopeptide discrimination. publication-title: J. Biol. Chem. – volume: 194 start-page: 1127 year: 2006 end-page: 1134 article-title: A polymorphism in Toll‐interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. publication-title: J. Infect. Dis. – volume: 170 start-page: 3451 year: 2003 end-page: 3454 article-title: Cutting edge: A Toll‐like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. publication-title: J. Immunol. – volume: 2 start-page: 967 year: 2001 end-page: 977 article-title: Genetics of susceptibility to human infectious disease. publication-title: Nat. Rev. Genet. – volume: 5 start-page: 156 year: 2005 end-page: 164 article-title: Single nucleotide polymorphisms of Toll‐like receptors and susceptibility to infectious disease. publication-title: Lancet Infect. Dis. – volume: 188 start-page: 938 year: 2003 end-page: 943 article-title: Heterozygous Toll‐like receptor 4 polymorphism does not influence lipopolysaccharide‐induced cytokine release in human whole blood. publication-title: J. Infect. Dis. – volume: 11 start-page: 600 year: 1999 end-page: 605 article-title: Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. publication-title: Cytokine – volume: 4 start-page: 937 year: 2002 end-page: 944 article-title: The role of Toll‐like receptors in immunity against mycobacterial infection. publication-title: Microbes Infect. – volume: 124 start-page: 783 year: 2006 end-page: 801 article-title: Pathogen recognition and innate immunity. publication-title: Cell – volume: 281 start-page: 9049 year: 2006 end-page: 9057 article-title: TLR1‐ and TLR6‐independent recognition of bacterial lipoeptides. publication-title: J. Biol. Chem. – volume: 175 start-page: 2534 year: 2005 end-page: 2540 article-title: Heterozygous Arg753Gln polymorphism of human TLR‐2 impairs immune activation by and protects from late stage Lyme disease. publication-title: J. Immunol. – volume: 72 start-page: 1657 year: 2004 end-page: 1665 article-title: Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll‐like receptors 2 and 6. publication-title: Infect. Immun. – volume: 299 start-page: 2076 year: 2003 end-page: 2079 article-title: Pyogenic bacterial infections in humans with IRAK‐4 deficiency. publication-title: Science – volume: 4 start-page: 499 year: 2004 end-page: 511 article-title: Toll‐like receptor signalling. publication-title: Nat. Rev. Immunol. – volume: 102 start-page: 2487 year: 2005 end-page: 2489 article-title: Toll‐like receptor 4 polymorphisms are associated with resistance to Legionnaires’ disease. publication-title: Proc. Natl. Acad. Sci. USA – volume: 202 start-page: 1715 year: 2005 end-page: 1724 article-title: TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to . publication-title: J. Exp. Med. – volume: 27 start-page: 705 year: 1988 end-page: 716 article-title: Endotoxin‐stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. publication-title: Scand. J. Immunol. – volume: 25 start-page: 187 year: 2000 end-page: 191 article-title: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. publication-title: Nat. Gen. – volume: 1 start-page: 58 year: 2001 end-page: 75 article-title: Haplotype analysis in population‐based association studies. publication-title: Stata Journal – volume: 20 start-page: 197 year: 2002 end-page: 216 article-title: Innate immune recognition. publication-title: Annu. Rev. Immunol. – volume: 120 start-page: 1 year: 2006 end-page: 9 article-title: Towards subtlety: Understanding the role of toll‐like receptor signaling in susceptibility to human infections. publication-title: Clin. Immunol. – volume: 163 start-page: 3920 year: 1999 end-page: 3927 article-title: Human Toll‐like receptors mediate cellular activation by . publication-title: J. Immunol. – volume: 285 start-page: 732 year: 1999 end-page: 736 article-title: Host defense mechanisms triggered by microbial lipoproteins through Toll‐like receptors. publication-title: Science – volume: 349 start-page: 170 year: 1997 end-page: 173 article-title: Genetic influence on cytokine production and fatal meningococcal disease. publication-title: Lancet – volume: 39 start-page: 523 year: 2007 end-page: 528 article-title: A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. publication-title: Nat. Genet. – volume: 167 start-page: 987 year: 2001 end-page: 994 article-title: Cooperation of Toll‐like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and outer surface protein A lipoprotein: Role of Toll‐interacting protein and IL‐1 receptor signaling molecules in Toll‐like receptor 2 signaling. publication-title: J. Immunol. – volume: 175 start-page: 2570 year: 2005 end-page: 2578 article-title: Identification of high and low responders to lipopolysaccharide in normal subjects: An unbiased approach to identify modulators of innate immunity. publication-title: J. Immunol. – volume: 103 start-page: 177 year: 2006 end-page: 182 article-title: Toll‐like receptor (TLR) polymorphisms in African children: Common TLR‐4 variants predispose to severe malaria. publication-title: Proc. Natl. Acad. Sci. USA – ident: e_1_2_7_46_2 doi: 10.1073/pnas.0506803102 – ident: e_1_2_7_9_2 doi: 10.1038/35021228 – ident: e_1_2_7_10_2 doi: 10.1038/nri1391 – ident: e_1_2_7_18_2 doi: 10.1073/pnas.0501165102 – ident: e_1_2_7_19_2 doi: 10.1126/science.1081902 – ident: e_1_2_7_31_2 doi: 10.1073/pnas.96.25.14459 – ident: e_1_2_7_22_2 doi: 10.1016/j.clim.2006.02.003 – ident: e_1_2_7_33_2 doi: 10.1126/science.285.5428.732 – ident: e_1_2_7_37_2 doi: 10.4049/jimmunol.167.2.987 – ident: e_1_2_7_27_2 doi: 10.1128/IAI.72.3.1657-1665.2004 – ident: e_1_2_7_11_2 doi: 10.1146/annurev.immunol.20.083001.084359 – ident: e_1_2_7_40_2 doi: 10.1086/378095 – ident: e_1_2_7_13_2 doi: 10.1038/76048 – ident: e_1_2_7_16_2 doi: 10.1073/pnas.0409831102 – ident: e_1_2_7_41_2 doi: 10.1016/j.clim.2006.01.005 – ident: e_1_2_7_15_2 doi: 10.1086/507907 – ident: e_1_2_7_45_2 doi: 10.1074/jbc.M610340200 – volume: 5 start-page: 156 year: 2005 ident: e_1_2_7_21_2 article-title: Single nucleotide polymorphisms of Toll‐like receptors and susceptibility to infectious disease. publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(05)01308-3 contributor: fullname: Schroder N. W. – ident: e_1_2_7_1_2 doi: 10.1038/35103577 – ident: e_1_2_7_3_2 doi: 10.1146/annurev.genom.2.1.373 – ident: e_1_2_7_5_2 doi: 10.1111/j.1365-3083.1988.tb02404.x – ident: e_1_2_7_12_2 doi: 10.1038/nature04946 – ident: e_1_2_7_39_2 doi: 10.1084/jem.20022078 – ident: e_1_2_7_17_2 doi: 10.1084/jem.20031220 – ident: e_1_2_7_43_2 doi: 10.1038/ng1976 – ident: e_1_2_7_4_2 doi: 10.1056/NEJM198803243181202 – ident: e_1_2_7_8_2 doi: 10.1006/cyto.1998.0471 – ident: e_1_2_7_14_2 doi: 10.1038/ni1116 – ident: e_1_2_7_47_2 doi: 10.1101/gr.8.3.195 – ident: e_1_2_7_49_2 doi: 10.1016/j.humimm.2005.04.009 – ident: e_1_2_7_29_2 doi: 10.4049/jimmunol.169.1.10 – ident: e_1_2_7_23_2 doi: 10.1016/j.cell.2006.02.015 – ident: e_1_2_7_34_2 doi: 10.1016/S1286-4579(02)01611-8 – volume: 1 start-page: 58 year: 2001 ident: e_1_2_7_50_2 article-title: Haplotype analysis in population‐based association studies. publication-title: Stata Journal doi: 10.1177/1536867X0100100104 contributor: fullname: Mander A. P. – ident: e_1_2_7_38_2 doi: 10.1097/01.MIB.0000195389.11645.ab – volume: 163 start-page: 3920 year: 1999 ident: e_1_2_7_30_2 article-title: Human Toll‐like receptors mediate cellular activation by Mycobacterium tuberculosis. publication-title: J. Immunol. doi: 10.4049/jimmunol.163.7.3920 contributor: fullname: Means T. K. – ident: e_1_2_7_35_2 doi: 10.1038/nm864 – ident: e_1_2_7_42_2 doi: 10.1128/IAI.68.11.6398-6401.2000 – ident: e_1_2_7_6_2 doi: 10.1016/S0140-6736(96)06413-6 – ident: e_1_2_7_44_2 doi: 10.1074/jbc.M504320200 – ident: e_1_2_7_32_2 doi: 10.4049/jimmunol.170.7.3451 – ident: e_1_2_7_24_2 doi: 10.1002/eji.200424955 – ident: e_1_2_7_7_2 doi: 10.4049/jimmunol.175.4.2570 – ident: e_1_2_7_26_2 doi: 10.1002/1521-4141(200212)32:12<3337::AID-IMMU3337>3.0.CO;2-# – ident: e_1_2_7_36_2 doi: 10.1084/jem.20051782 – ident: e_1_2_7_2_2 doi: 10.1146/annurev.immunol.20.081501.125851 – ident: e_1_2_7_25_2 doi: 10.1074/jbc.M512525200 – ident: e_1_2_7_20_2 doi: 10.4049/jimmunol.175.4.2534 – ident: e_1_2_7_28_2 doi: 10.1093/intimm/13.7.933 – volume: 212 start-page: 241 year: 2003 ident: e_1_2_7_48_2 article-title: MALDI‐TOF mass spectrometry‐based SNP genotyping. publication-title: Methods Mol. Biol. contributor: fullname: Storm N.
SSID	ssj0009659 ssj0013055
Score	2.3662317
Snippet	Toll‐like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways... Toll-like receptors (TLR) are critical mediators of the immune response to pathogens and human polymorphisms in this gene family regulate inflammatory pathways...
SourceID	proquest crossref pubmed wiley
SourceType	Aggregation Database Index Database Publisher
StartPage	2280
SubjectTerms	Bacterial Proteins - immunology Base Sequence Fluorescent Antibody Technique Genetics Humans Immunity, Innate Immunoblotting Infectious diseases Inflammation Innate immunity Lipoproteins - immunology Mycobacterium tuberculosis Mycobacterium tuberculosis - immunology NF-kappa B Polymerase Chain Reaction Polymorphism, Single Nucleotide Toll-Like Receptor 1 - genetics Transfection
Title	A common human TLR1 polymorphism regulates the innate immune response to lipopeptides
URI	https://onlinelibrary.wiley.com/doi/abs/10.1002%2Feji.200737034 https://www.ncbi.nlm.nih.gov/pubmed/17595679 https://search.proquest.com/docview/19711603 https://search.proquest.com/docview/68106690
Volume	37
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwEB1VSCAupVBalhbwoeIWcNZ2nBwRBVFUekCLxC21HVsKH8lqs3tYfj3jOLurpQIJ9ZYocWJ7ZuyxPfMewA-Wci2ZYJGwVkdcZCzSLkvQrpRmTqXcGJ8ofPUnubjhl7fituM59bkwAR9ivuHmLaMdr72BK90cL0BD7V3ZJpIz1FmPBxoz6UP6fl4v4KM8WF4YiXnUz1LaYWxi-eOl0stz0j-O5rLf2k485xvwd1blEG9yfzQZ6yPz9ALN8T_a9Ak-dk4pOQlatAkfbLUFq4GmcroFa1fdAfxnuDkh-E1UXdKS-5HB7-uYDOuH6WONAiubRzIK5Pa2IehakrKq8JqUPgvF4rM2INeScU0eymE99CE1hW22YXB-Nji9iDpmhshwKXiEK3Cb4srSSKmcNiou-oZr7vnTnTVCcsEENYmjrHCJVDRz6DYWxhVUG0kt-wIrVV3ZHSDc882wfmpdUnBq4jTDmUAxrgrDqaNxDw5nosmHAX8jD0jL_Rx7K5_3Vg8OZoLL0UL8sYeqbD1p8jiTsSfTfv0Nj8mWJBntwdcg8cWvpMAFpMx6QFu5vV2H_Ozy1_xm9_1FvsF62Dr28YXfYWU8mtg99HnGer9V7GfbI_jI
link.rule.ids	314,780,784,1375,27924,27925,46294,46718
linkProvider	Wiley-Blackwell
linkToHtml	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB5RUAsXaGmBBVp8qHoLOGs7To6Ihxa6ywEtErfIdmwpFJIVu3uAX8843gfbqpUqbokSO45nxh7bM98H8J2lXEsmWCSs1REXGYu0yxK0K6WZUyk3xicK966Szg2_vBW3r7L4Az7EbMPNW0YzXnsD9xvSR3PUUHtXNpnkDJWWv4MVNPnYB3WdXs8BpDxcXhiLedTOUjpB2cQKjhaKL85Kf7iai55rM_Wcb4CaNjpEnPw6HI_0oXn-Dc_xLX_1EdYnfik5Dor0CZZstQnvA1Pl0yZ86E3O4D_DzTHBSlF7ScPvR_rd65gM6vunhxplVg4fyGPgt7dDgt4lKasKr0npE1EsPmtici0Z1eS-HNQDH1VT2OEX6J-f9U860YScITJcCh7hItymuLg0UiqnjYqLtuGaewp1Z42QXDBBTeIoK1wiFc0ceo6FcQXVRlLLtmC5qiu7A4R7yhnWTq1LCk5NnGY4GSjGVWE4dTRuwY-pbPJBgODIA9hyO8feyme91YKDqeRyNBJ_8qEqW4-HeZzJ2PNp__0ND8uWJBltwXYQ-fxTUuAaUmYtoI3g_t2G_OzyYnaz-_9FDmC10-918-7F1c89WAs7yT7ccB-WR49j-xVdoJH-1mj5C34-_Ok
linkToPdf	http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3BTtwwEB21VEW9QEtL2UKLD1VvASe24_iICiuggCq0SNzS2LGltJBE7O6Bfn3HcXZXS0Ul1FuixI7jmbHH9sx7AJ9ZxrVkgkXCWh1xoViknUrRrgrNXJFxY3yi8PlFenzFT6_Fdc9z6nNhAj7EfMPNW0Y3XnsDb0u3vwANtT-rLpGcoc7y5_CCp4ny4PmHlwv8KI-WF4ZiHiUqoz3IJlawv1R8eVL6y9Ncdly7mWe4Dj9mbQ4BJ7_2phO9Z34_gHP8j596DWu9V0oOghq9gWe23oCXgafyfgNWz_sT-LdwdUCwTtRd0rH7kdHZZUza5ub-tkGJVeNbchfY7e2YoG9JqrrGa1L5NBSLz7qIXEsmDbmp2qb1MTWlHb-D0fBo9PU46qkZIsOl4BEuwW2GS0sjZeG0KeIyMVxzT6DurBGSCyaoSR1lpUtlQZVDv7E0rqTaSGrZJqzUTW23gHBPOMOSzLq05NTEmcKpoGC8KA2njsYD-DITTd4GAI48QC0nOfZWPu-tAezOBJejifhzj6K2zXScx0rGnk378Tc8KFuaKjqA90Hii09JgStIqQZAO7n9uw350enJ_ObD04vswur3w2F-dnLxbRtehW1kH2u4AyuTu6n9iP7PRH_qdPwPhiv7mA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+common+human+TLR1+polymorphism+regulates+the+innate+immune+response+to+lipopeptides&rft.jtitle=European+journal+of+immunology&rft.au=Hawn%2C+Thomas+R&rft.au=Misch%2C+E+Ann&rft.au=Dunstan%2C+Sarah+J&rft.au=Thwaites%2C+Guy+E&rft.date=2007-08-01&rft.issn=0014-2980&rft.volume=37&rft.issue=8&rft.spage=2280&rft_id=info:doi/10.1002%2Feji.200737034&rft_id=info%3Apmid%2F17595679&rft.externalDocID=17595679
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2980&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2980&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2980&client=summon